- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03676543
Mutual Interactions Between Absence Epilepsy Seizures and the Integration of Sensory Stimuli (Absence SLI)
September 19, 2022 updated by: Fondation Ophtalmologique Adolphe de Rothschild
Epileptic seizures arise from neuronal defects that often alter the capacity of the brain to process sensory information.
During absence seizures, a frequent epileptic syndrome in children, the normal conscious and perceptual processes are temporarily interrupted.
This is the result of abnormal synchronized neural activities in the thalamo-cortical loops, leading to bilateral spike-and-wave discharges (SWDs) in the cortical electroencephalograms (EEGs).
The brain mechanisms underlying the lack of sensory experience during absence seizures are disputed.
Based on preliminary data, the investigators hypothesize that the alternation of 'spike' and 'wave' patterns during seizure could cause a time-to-time inconstancy in cortical responsiveness, preventing conscious perception.
Using a real-time closed-loop stimulation system, the investigators will research how the S- and W-patterns specifically alter the sensory-evoked responses in the EEG.
During a standard EEG, visual stimulations will be applied between and during absence seizures to test the hypothesis that repeated sensory stimuli, applied with an appropriate timing relative to the seizure-related oscillatory cycle, could negatively interfere with the regenerative network mechanisms involved in the occurrence of SWDs.
The completion of this project should permit to unveil a new neuronal mechanism supporting the lack of conscious experience during absences and pave the way for new clinical non-invasive strategies to interrupt ongoing seizure activity.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Paris, France
- Fondation OPH A. de Rothschild
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 21 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria :
- Age 2-20 years
- childhood or juvenile absence epilepsy defined by International Ligue Against Epilepsy (ILAE)
- Electroencephalogram (EEG) indicated for clinical follow-up
Non inclusion criteria:
- Visual deficit
- Abnormal Magnetic Resonance Imaging (MRI)
- Medical history of photosensitive epileptic seizures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Timed repetitive sensory stimulation
Timed repetitive sensory stimulation (TRSS) will be applied at the onset or during seizures
|
Timed repetitive sensory stimulation (TRSS) will be applied at the onset or during seizures
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Modification of the frequency within the peak-wave complexes according to the repeated sensory stimulation and the duration of the absence epilespy crisis
Time Frame: 1 hour
|
Modification of the frequency within the peak-wave complexes according to the repeated sensory stimulation and the duration of the absence epilespy crisis
|
1 hour
|
Modification of the duration of the absence epilespy crisis according to the repeated sensory stimulation
Time Frame: 1 hour
|
Modification of the duration of the absence epilespy crisis according to the repeated sensory stimulation
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 7, 2018
Primary Completion (Actual)
August 29, 2022
Study Completion (Actual)
August 29, 2022
Study Registration Dates
First Submitted
July 31, 2018
First Submitted That Met QC Criteria
September 17, 2018
First Posted (Actual)
September 18, 2018
Study Record Updates
Last Update Posted (Actual)
September 21, 2022
Last Update Submitted That Met QC Criteria
September 19, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MCX_2017_28
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood or Juvenile Absence Epilepsy
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
UCB Biopharma SRLRecruitingChildhood Absence Epilepsy | Juvenile Absence EpilepsyUnited States, Australia, Georgia, Italy, Poland, Romania, Slovakia, Spain, Ukraine, Belgium
-
UCB Biopharma SRLEnrolling by invitationChildhood Absence Epilepsy | Juvenile Absence EpilepsyUnited States, Georgia, Italy, Romania, Ukraine, Slovakia, Spain
-
UCB Biopharma SRLNot yet recruitingChildhood Absence Epilepsy | Juvenile Absence Epilepsy
-
Assistance Publique - Hôpitaux de ParisCompletedChildhood Absence Epilepsy [Pyknolepsy]France
-
Eysz, Inc.University of Colorado, Denver; Wake Forest University Health Sciences; Children...Not yet recruitingChildhood Absence Epilepsy | Absence Seizures | Epilepsy ComorbiditiesUnited States
-
Radius Pharmaceuticals, Inc.TerminatedChildhood Absence EpilepsyUnited States
-
Radius Pharmaceuticals, Inc.Benuvia Therapeutics Inc.TerminatedChildhood Absence EpilepsyUnited States
-
Yale UniversityNational Institutes of Health (NIH)CompletedChildhood Absence EpilepsyUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Ortho-McNeil Neurologics, Inc.CompletedEpilepsy, Absence
Clinical Trials on Timed repetitive sensory stimulation
-
VA Office of Research and DevelopmentCompleted
-
Ruhr University of BochumUnknownComplex Regional Pain Syndrome Type I of the Upper LimbGermany
-
Sheba Medical CenterWeizmann Institute of ScienceCompletedParkinson's DiseaseIsrael
-
Tanta UniversityRecruiting
-
Xuzhou Central HospitalThe Affiliated Hospital of Xuzhou Medical UniversityNot yet recruitingFunctional Magnetic Resonance Imaging | Executive Function Disorder
-
Al-Azhar UniversityCompleted
-
Guangzhou Psychiatric HospitalCompletedCognitive Impairment | Bipolar Disorder | RelapseChina
-
Fatih Sultan Mehmet Training and Research HospitalCompletedFailed Back Surgery Syndrome
-
Veterans Medical Research FoundationUnited States Department of DefenseCompletedHeadache | Gulf War SyndromeUnited States
-
Hospices Civils de LyonNot yet recruitingPost-stroke Sensory Deficits at the HandFrance